Inflammatory diseases and bone health in children

Current Opinion in Rheumatology

Volumn 24, Issue 5, 2012, Pages 548-553

  Burnham, Jon M ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

Fracture; glucocorticoid; inflammation; juvenile idiopathic arthritis; osteoporosis

Indexed keywords

GLUCOCORTICOID; INTERLEUKIN 1; INTERLEUKIN 17; INTERLEUKIN 6; OSTEOCLAST DIFFERENTIATION FACTOR; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

BONE DENSITY; BONE DEVELOPMENT; BONE EROSION; BONE FRAGILITY; BONE MASS; BONE STRENGTH; COMPRESSION FRACTURE; CORTICOSTEROID INDUCED OSTEOPOROSIS; CROHN DISEASE; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; DUAL ENERGY X RAY ABSORPTIOMETRY; FRACTURE; HUMAN; IMMOBILIZATION; INFLAMMATORY DISEASE; JUVENILE RHEUMATOID ARTHRITIS; MALNUTRITION; NEPHROTIC SYNDROME; OSTEOPENIA; PRIORITY JOURNAL; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; VERTEBRA FRACTURE; WEIGHT GAIN;

ARTHRITIS, JUVENILE RHEUMATOID; BONE AND BONES; BONE DENSITY; BONE DEVELOPMENT; CHILD; FRACTURES, BONE; GLUCOCORTICOIDS; HUMANS; INFLAMMATION; RISK FACTORS;

EID: 84864885022     PISSN: 10408711     EISSN: 15316963     Source Type: Journal    
DOI: 10.1097/BOR.0b013e328356b0c2     Document Type: Review

References (36)

1. Burnham JM, Shults J, Weinstein R, et al. Childhood onset arthritis is associated with an increased risk of fracture: a population based study using the General Practice Research Database. Ann Rheum Dis 2006; 65:1074-1079.
2. Burnham JM, Shults J, Dubner SE, et al. Bone density, structure, and strength in juvenile idiopathic arthritis: importance of disease severity and muscle deficits. Arthritis Rheum 2008; 58:2518-2527.
3. Roth J, Palm C, Scheunemann I, et al. Musculoskeletal abnormalities of the forearm in patients with juvenile idiopathic arthritis relate mainly to bone geometry. Arthritis Rheum 2004; 50:1277-1285.
4. Huber AM, Gaboury I, Cabral DA, et al. Prevalent vertebral fractures among children initiating glucocorticoid therapy for the treatment of rheumatic disorders. Arthritis Care Res (Hoboken) 2010; 62:516-526.
5. Rodd C, Lang B, Ramsay T, et al. Incident vertebral fractures among children with rheumatic disorders 12 months after glucocorticoid initiation: a national observational study. Arthritis Care Res (Hoboken) 2012; 64:122-131.
6. Mitchell BD, Yerges-Armstrong LM. The genetics of bone loss: challenges and prospects. J Clin Endocrinol Metab 2011; 96:1258-1268.
7. Rauch F, Schoenau E. The developing bone: slave or master of its cells and moleculesi Pediatr Res 2001; 50:309-314.
8. Schoenau E, Neu CM, Rauch F, Manz F. The development of bone strength at the proximal radius during childhood and adolescence. J Clin Endocrinol Metab 2001; 86:613-618.
9. Schoenau E. From mechanostat theory to development of the 'Functional Muscle-Bone-Unit'. J Musculoskelet Neuronal Interact 2005; 5:232-238.
10. Burnham JM, Leonard MB. Bone mineral acquisition in utero and during infancy and childhood. In: Marcus R, Feldman D, Nelson D, Rosen C, editors. Elsevier Inc., Osteoporosis. 3rd ed. 2007. pp. 705-742.
11. Kontulainen S, Sievanen H, Kannus P, et al. Effect of long-term impact-loading on mass, size, and estimated strength of humerus and radius of female racquet-sports players: a peripheral quantitative computed tomography study between young and old starters and controls. J Bone Miner Res 2003; 18:352-359.
12. Almeida M, Han L, Ambrogini E, et al. Glucocorticoids and tumor necrosis factor alpha increase oxidative stress and suppress Wnt protein signaling in osteoblasts. J Biol Chem 2011; 286:44326-44335.
13. Okamoto K, Takayanagi H. Regulation of bone by the adaptive immune system in arthritis [review]. Arthritis Res Ther 2011; 13:219.
14. Sato K, Suematsu A, Okamoto K, et al. Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction. J Exp Med 2006; 203:2673-2682.
15. Harre U, Georgess D, Bang H, et al. Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin. J Clin Invest 2012; 122:1791-1802.
16. Canalis E, Mazziotti G, Giustina A, Bilezikian JP. Glucocorticoid-induced osteoporosis: pathophysiology and therapy. Osteoporos Int 2007; 18:1319-1328.
17. Bonewald LF. The amazing osteocyte. J Bone Miner Res 2011; 26:229-238.
18. Ward LM, Rauch F, Matzinger MA, et al. Iliac bone histomorphometry in children with newly diagnosed inflammatory bowel disease. Osteoporos Int 2010; 21:331-337.
19. Tuchman S, Thayu M, Shults J, et al. Interpretation of biomarkers of bone metabolism in children: impact of growth velocity and body size in healthy children and chronic disease. J Pediatr 2008; 153:484-490.
20. Rusconi R, Corona F, Grassi A, Carnelli V. Age at menarche in juvenile rheumatoid arthritis. J Pediatr Endocrinol Metab 2003; 16 (Suppl. 2):285-288.
21. Rygg M, Pistorio A, Ravelli A, et al. A longitudinal PRINTO study on growth and puberty in juvenile systemic lupus erythematosus. Ann Rheum Dis 2012; 71:511-517.
22. Aikawa NE, Sallum AM, Leal MM, et al. Menstrual and hormonal alterations in juvenile dermatomyositis. Clin Exp Rheumatol 2010; 28:571-575.
23. Gilsanz V, Chalfant J, Kalkwarf H, et al. Age at onset of puberty predicts bone mass in young adulthood. J Pediatr 2011; 158:100-105, 105.e1-105.e2.
24. Roubenoff R. Rheumatoid cachexia: a complication of rheumatoid arthritis moves into the 21st century. Arthritis Res Ther 2009; 11:108.
25. Bechtold S, Ripperger P, Dalla Pozza R, et al. Musculoskeletal and functional muscle-bone analysis in children with rheumatic disease using peripheral quantitative computed tomography. Osteoporos Int 2005; 16:757-763.
26. Felin EM, Prahalad S, Askew EW, Moyer-Mileur LJ. Musculoskeletal abnormalities of the tibia in juvenile rheumatoid arthritis. Arthritis Rheum 2007; 56:984-994.
27. Zemel BS. Quantitative computed tomography and computed tomography in children. Curr Osteoporos Rep 2011; 9:284-290.
28. Burnham JM, Shults J, Semeao E, et al. Whole body BMC in pediatric Crohn disease: independent effects of altered growth, maturation, and body composition. J Bone Miner Res 2004; 19:1961-1968.
29. Leonard MB, Feldman HI, Shults J, et al. Long-term, high-dose glucocorticoids and bone mineral content in childhood glucocorticoid-sensitive nephrotic syndrome. N Engl J Med 2004; 351:868-875.
30. Burnham JM, Shults J, Petit MA, et al. Alterations in proximal femur geometry in children treated with glucocorticoids for Crohn disease or nephrotic syndrome: impact of the underlying disease. J Bone Miner Res 2007; 22:551-559.
31. Dubner SE, Shults J, Baldassano RN, et al. Longitudinal assessment of bone density and structure in an incident cohort of children with Crohn's disease. Gastroenterology 2009; 136:123-130.
32. Wetzsteon RJ, Shults J, Zemel BS, et al. Divergent effects of glucocorticoids on cortical and trabecular compartment BMD in childhood nephrotic syndrome. J Bone Miner Res 2009; 24:503-513.
33. Markula-Patjas KP, Valta HL, Kerttula LI, et al. Prevalence of vertebral compression fractures and associated factors in children and adolescents with severe juvenile idiopathic arthritis. J Rheumatol 2012; 39:365-373.
34. Makitie O, Doria AS, Henriques F, et al. Radiographic vertebral morphology: a diagnostic tool in pediatric osteoporosis. J Pediatr 2005; 146:395-401.
35. Valta H, Lahdenne P, Jalanko H, et al. Bone health and growth in glucocorticoid-treated patients with juvenile idiopathic arthritis. J Rheumatol 2007; 34:831-836.
36. Nakhla M, Scuccimarri R, Duffy KN, et al. Prevalence of vertebral fractures in children with chronic rheumatic diseases at risk for osteopenia. J Pediatr 2009; 154:438-443.